A number of stocks fell in the afternoon session after stocks gave back some of the gains from the previous day as the White ...

Relay Therapeutics, Inc.’s RLAY share price has dipped by 6.00%, which has investors questioning if this is right time to buy.

Earnings results often indicate what direction a company will take in the months ahead. With Q4 behind us, let’s have a look ...

Protalix BioTherapeutics is profitable with key pipeline momentum and strategic interest. Check out why PLX stock is a strong ...

Biotech leaders urge Senate intervention as FDA restructuring risks expertise loss impacting operations. Read more here.

Pfizer’s PFE stock hit a new 52-week low of $20.92 on Wednesday but recovered thereafter and closed at $22.49 Though the ...

The global organ on a chip market was valued at US$ 157.06 million in 2024 and is expected to reach US$ 2,238.28 million by ...

Patients with pemphigus in complete remission had a reduced risk of relapse after receiving an additional rituximab infusion at month 6, according to a study.In the RITUX 3 trial, patients with ...

Real-time index price for PHLX Swiss Franc (XDS), along with buy or sell indicators, analysis, charts, historical performance, news and more ...

AstraZeneca’s share price has fallen a long way from its September high, but this may mean an opportunity for me to buy a great stock at a knockdown price.

Vinay Prasad, a hematologist-oncologist known for his vocal opposition to elements of the Covid response, also jumped on Cavazzoni’s move back to Pfizer in a same-day blog post titled “FDA approves ...

TABLE OF CONTENTS UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ___________________ SCHEDULE 14 A Proxy Statement Pursuant to Section 14 of the Securities Exchange Act of ...